GB1052224A - - Google Patents
Info
- Publication number
- GB1052224A GB1052224A GB1052224DA GB1052224A GB 1052224 A GB1052224 A GB 1052224A GB 1052224D A GB1052224D A GB 1052224DA GB 1052224 A GB1052224 A GB 1052224A
- Authority
- GB
- United Kingdom
- Prior art keywords
- hydrogen
- halogen
- lower alkyl
- ethinyl
- acyloxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1,052,224. Medicines comprising steroids. SCHERICO Ltd. Dec. 20, 1963 [Jan. 16, 1963 (2); March 7, 1963], No. 50366/63. Heading A5B. [Also in Division C2]. Therapeutic compositions having steroid hormone activity comprise a compound of the formula:- wherein A is (H,H), (H, α-Lower alkyl), (H, #-lower alkyl), lower alkylene, (H, α-hydroxy) or (H, α-acyloxy); B is hydrogen, lower alkyl or halogen; R is hydrogen, lower alkyl or acyl; of- X and Y, X is hydrogen or halogen and Y is a (H,H), Keto, (H, α-OR<SP>1</SP>), (H, #- OR<SP>1</SP>) or (H, #-halogen) R<SP>1</SP> being hydrogen or acyl, whereby X is hydrogen when Y is (H, H) or (H, α-OH), and X is halogen when Y is (H, #-halogen), or X and Y together represent an epoxy grouping or a double bond; and Z is one of the groupings D being hydrogen, lower alkyl, ethinyl, halogeno-ethinyl or alkyl-ethinyl, Q being hydrogen, hydroxy, acyloxy or halogen, R<SP>11</SP> being hydrogen or acyl and V being hydrogen, hydroxy or acyloxy, in admixture with a pharmaceutical carrier. Certain of the compounds have progestational and anti-fertility properties while others have anabolic and anti-inflammatory properties and are employed orally. Compounds having anti-inflammatory activity may, for example be administered in tablets or capsules, syrups, or emulsions intramuscularly in suspension, topically as a cream to which may be added neomycin sulphate, or in opthalmic suspensions or nasal sprays.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1052224T |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1052224A true GB1052224A (en) |
Family
ID=10870669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1052224D Active GB1052224A (en) |
Country Status (2)
Country | Link |
---|---|
BE (1) | BE642576A (en) |
GB (1) | GB1052224A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0095749A2 (en) * | 1982-05-28 | 1983-12-07 | E.R. Squibb & Sons, Inc. | 17-Spiroandrostenes |
-
0
- GB GB1052224D patent/GB1052224A/en active Active
- BE BE642576D patent/BE642576A/xx unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0095749A2 (en) * | 1982-05-28 | 1983-12-07 | E.R. Squibb & Sons, Inc. | 17-Spiroandrostenes |
EP0095749A3 (en) * | 1982-05-28 | 1985-01-09 | E.R. Squibb & Sons, Inc. | 17-spiroandrostenes |
Also Published As
Publication number | Publication date |
---|---|
BE642576A (en) |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0413269B1 (en) | 4-substituted 17-beta-(cyclopropyloxy)androst-5-EN-3-beta-OL and related compounds useful as C17-20 lyase inhibitors | |
US4081537A (en) | Δ15 -Steroids and pharmaceutical compositions thereof | |
US2793218A (en) | 9alpha-halo-11-keto-17-alkyltestosterones | |
GB1052224A (en) | ||
DE3872938T2 (en) | 17-BETA- (CYCLOPROPYLOXY) ANDROST-5-EN-3-BETA-OL DERIVATIVES AND RELATED COMPOUNDS AS C17-20 LYASE INHIBITORS. | |
EP0318490B1 (en) | 14,17-g(b)-ethano-14-g(b)-estratrienes, process for their manufacture and pharmaceutical preparations containing these | |
US3576828A (en) | Delta**4,9,11-trienes of the 19-nor-androstene series and process for their manufacture | |
DE4132182A1 (en) | 11 (BETA) SUBSTITUTED 14, 17-ETHANOESTRATRIA, METHOD FOR PRODUCING THESE COMPOUNDS, AND THEIR USE FOR THE PRODUCTION OF MEDICINAL PRODUCTS | |
GB1147802A (en) | Improvements in or relating to novel steroids and the manufacture thereof | |
US3301756A (en) | 19-nor steroids oxygenated in the 11-position, process of preparation and utilization | |
Dorfman et al. | Steroid anti-estrogens | |
US3138527A (en) | Topical anti-inflammatory process | |
US4081538A (en) | Aldosterone antagonists | |
US3272708A (en) | 20-aminomethyl-21-amino-pregnanes and therapeutic compositions thereof | |
US3984476A (en) | D-homo-19-norsteroids | |
US3167547A (en) | 17-tetrahydropyranyl ethers of 19-nor, 3-keto androstanes | |
EP0034114B1 (en) | 3-desoxy-delta-15 steroids, process for their preparation and pharmaceutical compositions containing them | |
US3842074A (en) | 18-methylene-steroids of the pregnane series | |
US3453296A (en) | Delta**1-7alpha-methyl-androstenes | |
US3691212A (en) | 17alpha-(1',3'-alkadiynyl)-17beta-acyloxy(17beta-aroyloxy) steroids | |
IL41506A (en) | 15alpha,16alpha-methylene-delta4-oestren-17beta-ols | |
DE1952461C3 (en) | 17 alpha-acetoxy-7 alpha-alkylthioprogesterone Process for their preparation and medicinal products containing them | |
US3126376A (en) | Fluorinated anbrostenes and inter- | |
EP1242445B1 (en) | 14,15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds | |
US3789087A (en) | 4,6-dichlor- {66 {11 {11 {11 -steroids and method of making and using the same |